Tokel Onur, Yildiz Umit Hakan, Inci Fatih, Durmus Naside Gozde, Ekiz Okan Oner, Turker Burak, Cetin Can, Rao Shruthi, Sridhar Kaushik, Natarajan Nalini, Shafiee Hadi, Dana Aykutlu, Demirci Utkan
Demirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Demirci Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Stanford University School of Medicine, Canary Center at Stanford for Cancer Early Detection, Palo Alto, CA, USA.
Sci Rep. 2015 Mar 24;5:9152. doi: 10.1038/srep09152.
Timely detection of infectious agents is critical in early diagnosis and treatment of infectious diseases. Conventional pathogen detection methods, such as enzyme linked immunosorbent assay (ELISA), culturing or polymerase chain reaction (PCR) require long assay times, and complex and expensive instruments, which are not adaptable to point-of-care (POC) needs at resource-constrained as well as primary care settings. Therefore, there is an unmet need to develop simple, rapid, and accurate methods for detection of pathogens at the POC. Here, we present a portable, multiplex, inexpensive microfluidic-integrated surface plasmon resonance (SPR) platform that detects and quantifies bacteria, i.e., Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) rapidly. The platform presented reliable capture and detection of E. coli at concentrations ranging from ~10(5) to 3.2 × 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis (PD) fluid. The multiplexing and specificity capability of the platform was also tested with S. aureus samples. The presented platform technology could potentially be applicable to capture and detect other pathogens at the POC and primary care settings.
及时检测感染因子对于传染病的早期诊断和治疗至关重要。传统的病原体检测方法,如酶联免疫吸附测定(ELISA)、培养或聚合酶链反应(PCR),需要较长的检测时间以及复杂且昂贵的仪器,这在资源有限的初级医疗环境中无法满足即时检测(POC)的需求。因此,开发用于在即时检测点简单、快速且准确地检测病原体的方法存在未满足的需求。在此,我们展示了一种便携式、多重、廉价的微流控集成表面等离子体共振(SPR)平台,该平台可快速检测和定量细菌,即大肠杆菌(E. coli)和金黄色葡萄球菌(S. aureus)。该平台在磷酸盐缓冲盐水(PBS)和腹膜透析(PD)液中,对浓度范围从约10⁵至3.2×10⁷CFU/mL的大肠杆菌实现了可靠的捕获和检测。该平台的多重检测和特异性能力也用金黄色葡萄球菌样本进行了测试。所展示的平台技术有可能适用于在即时检测点和初级医疗环境中捕获和检测其他病原体。